Background: Angiotensinogen is the substrate for renin in the system that releases angiotensin II. This renin-angiotensin system is an important regulator of blood pressure (BP), and defects in the system are linked to the development of hypertension. Native angiotensinogen is a 62,000-dalton monomer, but various high molecular weight forms also exist, which have not been well characterized. High molecular weight angiotensinogen has been reported to be 5% of the total angiotensinogen, and increases to 60% of the total during pregnancy and hypertension. The purpose of this investigation was to study high molecular weight angiotensinogen in normal plasma. Methods: Normal human plasma was run on a gel filtration column, and high molecular weight angiotensinogen detected by Western blotting. Further purification was by ion-exchange chromatography. In vitro polymerization of angiotensinogen was analyzed by sodium dodecyl sulfate (SDS) and native gels.
A ngiotensinogen (AGT) is the precursor of angiotensin I, which is produced by the action of renin. AGT has 452 amino acids, and a molecular weight of ϳ62,000 daltons, with some minor variations in mass reported due to glycosylation heterogeneity. 1 The majority of AGT in plasma under most circumstances is monomeric. However, high molecular weight AGT forms (HMW-AGT) have been identified, with about 3% to 5% of AGT in plasma from nonpregnant women and men eluting having a molecular weight of 450,000 to 500,000 daltons. The HMW-AGT is increased by estrogen and pregnancy, and is the predominant form in preeclampsia. 2, 3 The HMW-AGT is a heterogenous mixture of multiple forms of AGT. By ion-exchange chromatography up to five distinct peaks of HMW-AGT have been reported in plasma during pregnancy and from placenta.
2,4 -8 Some other forms of HMW-AGT are part of a complex with proMBP. The proform of eosinophil major basic protein (ProMBP) was found to form a 2:2 disulfide bonded complex with AGT. Another complex consisted of a 2:2:2 ratio of AGT, proMBP, and complement C3dg. 9, 10 These complexes are different from the five forms previously detected in the placenta. 5 Mutagenesis studies with AGT showed that the free cysteine at position 232 was responsible for forming a disulfide bond with proMBP. 11 The function of HMW-AGT has remained unclear because it is heterogeneous and poorly characterized, and it is not known where or how it is formed. The multiple, and potentially quite different, forms of HMW-AGT that exist make conclusions based on a total HMW-AGT pool somewhat preliminary. It has been reported that the K m of HMW-AGT for renin is about half that of AGT, [12] [13] [14] [15] [16] and that the rate of reaction is considerably slower. 14, 15 This would result in HMW-AGT being cleaved at about half the rate of AGT. In addition, the reaction of the AGTproMBP complex is seven times slower than the reaction with AGT. 11 These data support the idea that the function of HMW-AGT might be to reduce the reaction with renin and the formation of angiotensin I, with the increase in HMW-AGT seen in pregnancy and preeclampsia being a mechanism to aid in the reduction of blood pressure (BP), 16 although this hypothesis is without proof. An unusual feature of AGT is that it is a member of the serpin family of proteins, but in contrast to many other serpins it does not inhibit proteinases. 17 This is because it does not undergo the typical serpin conformational change after proteolytic cleavage within the reactive center loop region, and the presence of Val-Leu at the aligned P1-P1Ј positions, which are unlikely to be found in inhibitory serpins. 18 The significance of AGT being a serpin is not understood, especially given that angiotensin I consists of the first 10 amino acids of AGT in a region not present in other serpins. 18 -20 Given the clinical significance of hypertension, and the increase in understanding the structure-function relationships in the serpin family of proteins, 21 we considered that it was important to investigate the characteristics of HMW-AGT from normal plasma, and of AGT polymers produced in vitro.
Methods

Reagents
Purified human plasma AGT, neutrophil elastase, and cathepsin G were from Athens Research (Athens, GA). Polymers of AGT were produced by heating at 65°C, as described previously. 22 Recombinant human renin was from Hoffman-La Roche (Basel, Switzerland). Pooled normal human plasma was from Sigma Chemical Co. (St. Louis, MO). Reagents for staining of gels and development of blots were from Pierce (Rockford, IL). I 125 -Angiotensinogen was from AP Biotech (Arlington Heights, IL). N-Acetylated peptides corresponding to the P12-P2 sequence (PTESTQQLNKP), P12-P7 sequence (PTESTQ), and P7-P2 sequence (QQLNKP) of AGT were synthesized at the Protein Resource Laboratory of the University of Illinois at Chicago. The P12-P2 and P7-P2 peptides were dissolved in 2% formic acid at 6 mg/mL and neutralized with 1 mol/L Tris-HCl at pH 8.0 to a concentration of 2 mg/mL. The P12-P7 peptide was dissolved in 2% acetic acid instead of formic acid. To determine whether the peptides would form a binary complexes with AGT, AGT was incubated with a 100-fold molar excess of peptide at 37°C for 18 h in 20 mmol/L Tris-HCl at pH 7.4, 150 mmol/L NaCl, followed by electrophoresis on 7% acrylamide native gels, using methods previously described.
22,23
Assays for Angiotensinogen
AGT was detected in fractions eluting from gel-filtration and ion-exchange columns (discussed later) by Western blotting using rabbit antiangiotensinogen antibodies. 11 The location of HMW-AGT eluting from the gel filtration eluting confirmed using a radio-immunoassay for angiotensin I release by renin. 11, 20 Isolation Procedures for HMW-AGT Four milliliters of pooled plasma (from Sigma Chemical Co.) was loaded onto a calibrated Sephacryl S-300 16/60 column in 20 mmol/L Tris-HCl at pH 7.4, 50 mmol/L NaCl at 0.5 mL/min. The fraction collector was started after 30 mL had eluted. One-milliliter fractions were analyzed for the presence of HMW-AGT by Western blotting. In some cases the NaCl concentration was 1 mol/L. Samples containing HMW-AGT were pooled and loaded onto a HiPrep 16/10 DEAE Fast Flow column in 20 mmol/L Tris-HCl at pH 7.4, 50 mmol/L NaCl at 2 mL/ min. Samples were eluted at 2 mL/min using a gradient up to 1 mol/L NaCl over 100 min. Two-milliliter fractions were collected and analyzed for the presence of HMW-AGT by Western blotting.
Results
Characterization of HMW-AGT From Normal Plasma
Studies on HMW-AGT have focused on the protein in pregnancy, from plasma or placenta. HMW-AGT in plasma from men and nonpregnant women has received little attention, and there is no compelling hypothesis for the role of HMW-AGT in these cases, or are there data on the structures of any isoforms of HMW-AGT that might exist. Therefore, we investigated HMW-AGT in pooled normal plasma purchased from Sigma Chemical Co. To characterize HMW-AGT, the first step was to isolate the high molecular weight species. Because HMW-AGT might exist with both covalent and noncovalent interactions, the only way to be sure to isolate "intact" HMW-AGT was to start with a gel filtration column using a low salt concentration in the buffer. This limits the amount of starting material that can be used, making a large scale preparative purification not possible. Instead, these studies were designed to show that HMW-AGT can be isolated from pooled normal plasma. In addition, using Western blotting rather than angiotensin I release to detect HMW-AGT, these studies should give new information on the molecular weight and number of HMW-AGT isoforms present, rather than just showing the presence of the total HMW-AGT pool.
Plasma was run over a Sephacryl S-300 gel filtration column. Fig. 1 shows the elution profile with absorbance at 280 nm (diamonds), and the location of HMW-AGT (solid bar). Fig. 2 shows the Western blot on which two major bands of HMW-AGT are seen. The first was in fractions 16 to 27 (800,000 to 320,000 daltons), and centered at fraction 22 (500,000 daltons). The second was in fractions 20 to 36 (560,000 to 110,000 daltons), and centered at fraction 29 (250,000 daltons). A radio-immunoassay for angiotensin I released by renin was carried out to confirm this localization of HMW-AGT (Fig. 1, squares) , although this could not distinguish multiple forms of HMW-AGT. The large peak at the end of the chromatogram is due to native monomer AGT.
Although peak 1 eluted at 500,000 daltons, and peak 2 at 250,000 daltons, on the sodium dodecyl sulfate (SDS) gel and blot the molecular weights of these two bands were 140,000 and 110,000 daltons, respectively (Fig. 2) . The blots were from nonreduced SDS gels, and therefore noncovalent interactions would be disrupted but disulfide bonds would be intact. When ␤-mercaptoethanol was included, the bands at 140,000 and 110,000 daltons ran at 62,000 daltons, at the same location as AGT, showing that they contained AGT in a disulfide bonded complex with another protein (see Fig. 6 ). It is not known whether these two complexes contained only AGT, or whether other proteins were involved. However, Western blotting with antibodies to proMBP, as well as to C3d, showed that these proteins were not present, indicating that the complexes are different from those isolated previously. 14, 15 When the gel filtration was run using 1 mol/L salt in the buffer, peak 1 was no longer present, but peak 2 remained unaltered.
From these data we can suggest that peak 1 consists of AGT in a disulfide bonded complex of 140,000 daltons, which runs at 500,000 daltons on the gel filtration column probably because it has weak noncovalent interactions with itself or other proteins, which can be disrupted at high salt. Peak 2 consists of AGT in a disulfide bonded complex of 110,000 daltons, which runs at 250,000 daltons on a gel filtration column because of two possible reasons. The first is that it is asymmetric in shape, rather than globular, and   FIG. 3 . Western blot to detect high molecular weight angiotensinogen forms in ion exchange column fractions. Fifteen microliters of fractions from the DEAE column were run on 7.5% SDS-PAGE (nonreduced), and blotted with polyclonal antisera to angiotensinogen for detection of high molecular weight angiotensinogen forms. M ϭ molecular weight markers (165,000, 110,000, and 76,000 daltons); other abbreviation as in Fig. 2 . Note that not every fraction in the 4 to 31 range was included.
FIG. 1.
Elution of total protein and high molecular weight angiotensinogen forms from Sephacryl S-300. Four milliliters of plasma was loaded and the elution of protein detected at 280 nm is shown (diamonds, with absorbance shown on left axis). The position of molecular weight markers are indicated by arrows. The solid bar indicates fractions that contained high molecular weight angiotensinogen forms detected by blotting (see Fig. 3 ). Samples were also assayed for angiotensin I release by renin in a radioimmunoassay. The assay data is presented as the inverse of the counts per minute measured (squares, right axis). CPM ϭ counts per minute.
FIG. 2.
Western blot to detect high molecular weight angiotensinogen forms in gel filtration column fractions. Fifteen microliters of fractions 16 to 33 from the Sephacryl S-300 column were run on 7.5% SDS-PAGE (nonreduced), and blotted with polyclonal antisera to angiotensinogen for detection of high molecular weight angiotensinogen forms. M ϭ molecular weight markers (165,000, 110,000, and 76,000 daltons). SDS-PAGE ϭ sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
therefore runs with an anomalously high molecular weight. This would explain why elution was unaltered in high salt. The second is that the AGT could be forming typical serpin loop-sheet interactions with another molecule of AGT (discussed later), which could remain intact at high salt. To further purify HMW-AGT, the total HMW-AGT pool (fractions 16 to 36) was loaded onto DEAE-Sephadex. Fig. 3 shows a blot of the fractions, showing that the two forms can be well separated. Peak 1 eluted at 220 mmol/L NaCl and peak 2 at 315 mmol/L NaCl.
In Vitro Production of Angiotensinogen Polymers
One of the consequences of AGT being a serpin is that it will form polymers when heat denatured. 22 In this case, the reactive center loop region of one molecule of AGT is believed to incorporate noncovalently into a ␤-sheet of another AGT molecule to form so-called loop-sheet polymers, as described for other serpins. 22,24 -27 However, it has also been shown that polymers produced by heating are stable to SDS, and probably result from disulfide bonds involving Cys-232 or Cys-308. 20 To investigate this apparent discrepancy, AGT was heated at 65°C and run on a native gel (Fig. 4A) , and SDS gels without (Fig. 4B) , or with ␤-mercaptoethanol (Fig. 4C) . Polymers can be seen on the native gel and on the nonreduced SDS gel, both findings in agreement with earlier data. 20, 22 Polymers are not present in the reduced SDS gel. From the time course it is apparent that a covalent disulfide bonded polymer forms rapidly (Fig. 4B) , reaching a maximum by 1 min of incubation. There is one main band that probably represents an AGT dimer. Only a small fraction of the protein has formed this dimer, indicating that only a small population of the AGT has a free cysteine that can react to form a disulfide bond. In contrast, the polymers seen on the native gel have not formed until 5 min, and very high molecular weight species continue to increase with time. These noncovalent polymers represent the typical serpin loop-sheet polymers. 22,24 -27 These polymers are produced under nonphysiologic conditions, but there is a precedent that serpin polymerization by the same mechanisms occurs in vivo. In the case of the serpin antithrombin, noncovalent dimer formation can occur in vivo at normal body temperature. 27 Because AGT behaves in the typical serpin manner, it is possible that such interactions might occur in vivo. It has been suggested that some of the HMW-AGT species found in pregnancy plasma might be noncovalent AGT polymers. 6 Another way to assess whether the conformational change can occur is to incubate the serpin with a peptide with the sequence of the reactive center loop, and determine whether it incorporates into ␤-sheet A. 23, 26, 28 Therefore, AGT was incubated with three different peptides consisting of the P12-P2, P12-P7, and P7-P2 residues of AGT for 24 h at 37°C, and insertion assessed by a change in mobility on a native gel. No change in mobility indicative of peptide insertion was observed with any peptide. However, when AGT was incubated with the P7-P2 peptide, the AGT was induced to form polymers, rather than forming a binary peptide-AGT complex, as shown on a native gel (Fig. 5 ). This could mean that the peptide can insert into ␤-sheet A, but this "opening" of the ␤-sheet allows the reactive center loop of an adjacent molecule to insert and displace the peptide. There is precedent for this from other serpins where a similar phenomenon occurred. 26, 28 Evidence that the reactive center loop of AGT is exposed and flexible, in a manner typical of serpins, comes from data showing that it is susceptible to proteolytic cleavage.
17,20
Estimation of the Amount HMW-AGT in Plasma
This study is the first to use Western blotting to detect different HMW-AGT forms in plasma. Based on the sensitivity of the blots we can make an estimate of how much HMW-AGT was present in the plasma, and compare this with the expected amount. The concentration of AGT in plasma is 1 mol/L or 65 g/mL. In normal plasma HMW-AGT is reported to be ϳ5% of the total or 3. 25   FIG. 4 . In vitro polymerization of angiotensinogen. Angiotensinogen was heated at 65°C for the indicated times (minutes), and run on a native 7% acrylamide gel (A), a 7.5% acrylamide SDS gel (B), or a 7.5% acrylamide SDS gel with ␤-mercaptoethanol (C). Abbreviation as in Figs. 2 and 3 . g/mL. We loaded 4 mL of plasma onto the gel filtration column, therefore loading 13 g of HMW-AGT. HMW-AGT eluted in a total volume of ϳ20 mL, which would give a concentration of ϳ0.65 g/mL. Fifteen microliters of this pool would contain 9.75 ng of AGT present in HMW-AGT. In Fig. 6 ., a range of AGT was used on the Western blot, along with 15 L of the HMW-AGT pool, under denaturing and reducing conditions (SDS-polyacrylamide gel electrophoresis with ␤-mercaptoethanol) so that all of the AGT was monomeric. The intensity of the bands was determined and the calibration curve is shown in Fig.  6 . Based on the intensity of the AGT in the sample, this corresponds to ϳ20 ng, close to the predicted amount.
Discussion
The role of HMW-AGT in normotensive people is unknown, as is the importance of the increase seen in hypertension and pregnancy. Whether the function of HMW-AGT is to downregulate angiotensin II production as a response to elevated BP, or is itself a causative effect on some aspect of physiology is not known. The total HMW-AGT pool increases in pregnancy and hypertension, but only limited information is available on the concentration changes of the different isoforms. 5, 6, 10, 16 It is not known whether the two forms described here from normal plasma are the same as those found in pregnancy and hypertension.
A further complication in understanding HMW-AGT is the occurrence of the M235T mutation in AGT. This M235T mutant less readily forms a disulfide bonded complex with proMBP in vitro. 11 As these complexes form with Cys 232, and this cysteine is probably responsible for all disulfide bonds in HMW-AGT, it is possible that the production of HMW-AGT would be reduced when the M235T variant is present. A preliminary study comparing the amount of HMW-AGT (800,000 to 100,000 daltons) from plasma of third trimester pregnant and normotensive women with the MM genotype (n ϭ 3) versus the TT genotype (n ϭ 3) did not reveal any significative difference (Anne-Paule Gimenez-Roqueplo and Jérôme Celérier, unpublished data), although this was based on total HMW-AGT and different isoforms were not considered. Another way to view HMW-AGT is not that it regulates AGT function, but rather that AGT regulates the function of the proteins it is binding to. Although speculative, an example could be the complexes of AGT with proMBP, which although not detected here, have been found by other investigators. 9 -11 ProMBP inhibits the activity of a metzincin family metalloproteinase, called pregnancy-associated plasma protein A (PAPP-A), by forming a disulfide bonded complex. 29 It is possible that an increase in AGT-proMBP complexes might prevent proMBP from forming a complex with PAPP-A, thereby causing an increase in the proteolytic activity of PAPP-A. A similar phenomenon could occur as a result of formation of other HMW-AGT species.
An exciting recent finding is that AGT possesses antiangiogenic activity. 30 A consideration for future studies of HMW-AGT is whether HMW-AGT as a whole, or more particularly different HMW-AGT species, have altered activity in this regard. The ability to isolate different HMW-AGT species, such as shown here with normal plasma, will be critical in such studies. Finally, although AGT belongs to the serpin family of proteins, there is no clear reason why angiotensin I is part of a serpin and what role, if any, the serpin structural framework plays. One reason could be that the serpin structure confers a unique ability to regulate the reaction with renin, such as by the formation of HMW-AGT. 
